Loading...
Thumbnail Image
Publication

Host tropism determination by convergent evolution of immunological evasion in the Lyme disease system [preprint]

Hart, Thomas M.
Dupuis, II, Alan P.
Tufts, Danielle M.
Blom, Anna M.
Starkey, Simon
Rego, Ryan O. M.
Ram, Sanjay
Kraiczy, Peter
Kramer, Laura D.
Diuk-Wasser, Maria A.
... show 2 more
Embargo Expiration Date
Link to Full Text
Abstract

Microparasites selectively adapt in some hosts, known as host tropism. Transmitted through ticks and carried mainly by mammals and birds, the Lyme disease (LD) bacterium is a well-suited model to study such tropism. LD bacteria species vary in host ranges through mechanisms eluding characterization. By feeding ticks infected with different LD bacteria species, utilizing feeding chambers and live mice and quail, we found species-level differences of bacterial transmission. These differences localize on the tick blood meal, and complement, a defense in vertebrate blood, and a bacterial polymorphic protein, CspA, which inactivates complement by binding to a host complement inhibitor, FH. CspA selectively confers bacterial transmission to vertebrates that produce FH capable of allele-specific recognition. Phylogenetic analyses revealed convergent evolution as the driver of such findings, which likely emerged during the last glacial maximum. Our results identify LD bacterial determinants of host tropism, defining an evolutionary mechanism that shapes host-microparasite associations.

Source

bioRxiv 2021.02.09.430532; doi: https://doi.org/10.1101/2021.02.09.430532. Link to preprint on bioRxiv.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1101/2021.02.09.430532
PubMed ID
Other Identifiers
Notes

This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.

Funding and Acknowledgements
Corresponding Author
Related Resources

Now published in PLOS Pathogens doi: 10.1371/journal.ppat.1009801

Related Resources
Repository Citation
Rights
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.